Israel: Merger Control

The In-House Lawyer Logo

This country-specific Q&A provides an overview to merger control laws and regulations that may occur in Israel.

It will cover jurisdictional thresholds, the substantive test, process, remedies, penalties, appeals as well as the author’s view on planned future reforms of the merger control regime.

This Q&A is part of the global guide to Merger Control. For a full list of jurisdictional Q&As visit http://www.inhouselawyer.co.uk/index.php/practice-areas/merger-control-3rd-edition

  1. Overview

    The government authorities in charge of merger control in Israel are the Israeli Antitrust Commissioner (the “Commissioner”) and the Israeli Antitrust Authority. The Commissioner must consult with the Advisory Committee for Mergers and Exemptions before approving, rejecting or stipulating conditions for a merger.

    To fall within the boundaries of the merger control regime, a transaction must meet the definition of a "merger of companies", as well as the relevant filing thresholds.

    The definition of a "merger" is relatively broad and, in the Israeli Antitrust Authority's view, includes any transaction that grants one company a structural foothold in the management of another company's business. As detailed below, any acquisition of the main assets of a business, or acquisition of over 25% of certain rights in a company is considered a "merger".

    "Merger of companies" only exists if at least two "companies" are involved therein. The definition of a "company" includes cooperatives and partnerships, and includes a test of nexus to Israel.

    Filing thresholds are assessed by reference to turnover and to market share of both the merging parties. Filing is mandatory in the event parties cross a threshold of 50% market-share as a result of the transaction or one of the parties already has over 50% in any market. Turnovers and market shares refer only to Israel, but they refer to the entire group of companies under the same control. Thus, if two groups of companies which meet the thresholds perform a transaction outside Israel, they may still have to file in Israel. The thresholds do not contain or include any reference to transaction size or asset size.

    A merger transaction which falls below the thresholds is legal per se, and cannot be challenged in court. Ancillary restraints, such as non-compete clauses, require specific clearance, unless they meet the standards for a specific statutory exemption or block exemption.

    If a transaction is deemed a "merger transaction" and meets the relevant filing thresholds, filing is mandatory. The Commissioner will oppose a merger if there is "reasonable concern of significant harm" to competition or the public.

    The merger transaction cannot be consummated without approval from the Commissioner. The commissioner must grant his decision within 30 days of the filing. The 30-day period may be extended voluntarily by the parties or by the specialist Antitrust Tribunal in Jerusalem, by order of the Commissioner.

    Illegally-consummated mergers are subject to administrative fines, and possibly even criminal charges. In addition, the Commissioner may approach the Antitrust Tribunal and request divestiture. Illegal mergers are also subject to civil actions, including class actions.

  2. Is mandatory notification compulsory or voluntary?

    A transaction which falls under the definition of a "merger of companies" according to the Restrictive Trade Practices Law, 1988 (the "Israeli Antitrust Law"), and meets the relevant thresholds, must be filed. The Commissioner's consent is required before consummating the transaction. Gun-jumping is enforceable by various measures, including criminal charges and administrative fines.

  3. Is there a prohibition on completion or closing prior to clearance by the relevant authority? Are there possibilities for derogation or carve out?

    If the transaction falls under the definition of "merger of companies" according to the Israeli Antitrust Law and meets the relevant thresholds, it is illegal to complete the transaction before receiving the Israeli Commissioner's consent for completion of the transaction. However, if 30 days have elapsed since filing merger notifications and the Commissioner has not responded, the merger is considered approved.

    Any action which amounts to carrying out a notifiable merger transaction, or the first steps thereof, prior to receiving the Commissioner’s approval, may, in the Israeli Antitrust Authority's view, constitute gun-jumping. Any transfer of actual foothold or involvement in the operations of the acquired company may also be considered gun-jumping. Among other things, under certain circumstances, the following have been deemed gun-jumping:

    • A loan or transfer of funds to the acquired business;
    • Transfer of shares to trustees who are, effectively, the controlling owners of the acquiring company;
    • Transfer of the consideration, or part thereof, prior to the Commissioner's approval;
    • Transfer of risk with regard to the assets prior to the Commissioner's approval;
    • The appointment of officers in the company, including temporary members of the board.

    In international transactions, it is possible to carve the assets and legal entities in Israel out of the transaction, though generally, any carve-out outline will require the Israeli Antitrust Authority's approval.

    The Israeli Antitrust Authority does not normally allow exceptions, unless the acquired business is in severe financial distress and may not survive conclusion of the review. Thus, the Israeli Antitrust Authority may allow the prospective acquirer to transfer funds into the prospective target, under certain conditions.

  4. What types of transaction are notifiable or reviewable and what is the test for control?

    The definition of a "merger of companies" in section 1 of the Israeli Antitrust Law is an open definition, beginning with the word "including". According to the Antitrust Commissioner's Guidelines for Reporting and Evaluating Mergers under the Restrictive Trade Practices Law, 1988 (the "Guidelines"), this implies that the "merger of companies" definition has a "wide and general aspect", which a) does not expressly appear in the definition, and b) includes "any transaction that creates (or significantly strengthens) a substantial and continuous influence link between the decision-making mechanisms of the companies involved in the transaction, either directly or indirectly".

    In addition to this general aspect, the Israeli Antitrust Law includes a presumption that the following create a "merger of companies":

    • the acquisition of most of the assets of one company by another;
    • the acquisition of shares in one company by another, whereby the acquiring company is accorded more than a quarter (25%) of one of the below:
    • The nominal value of the issued share capital;
    • The voting power;
    • The power to appoint members of the board;
    • Sharing in the company's profits.

    The merger of companies definition applies whether the acquisition is direct or indirect or by way of rights accorded by contract.

  5. In which circumstances is an acquisition of a minority interest notifiable or reviewable?

    As mentioned, any acquisition of more than 25% of even one of the rights outlined above constitutes a merger of companies. In the past, the Israeli Antitrust Authority has not seen a "mergers of companies" transaction where less than 25% of the above rights were acquired, unless other factors existed, such as the appointment of company officers or actual involvement in the company's activities.

    Nonetheless, when made between competitors, an acquisition or holding of less than 25% may be considered a "restrictive arrangement", which, under certain circumstances, also requires clearance according to Israeli Antitrust Law.

  6. What are the jurisdictional thresholds (turnover, assets, market share and/or local presence)? Are there different thresholds that apply to particular sectors?

    Nexus to Israel

    When non-Israeli entities are involved in a transaction, the "merger of companies" definition will only apply to the transaction if at least two of the parties involved in the transaction are each deemed a "company" under the Israeli Antitrust Law; i.e. corporate entities with sufficient nexus to Israel (the "Nexus Test").

    As explained in the Guidelines, the Nexus Test is satisfied if the party is:

    • An Israeli company;
    • A non-Israeli company registered in Israel as a "foreign company";
    • A non-Israeli company not registered in Israel, but with a "merger affiliation" with an Israeli company. A "merger affiliation" includes, inter alia, a situation where the non-Israeli company, an entity who controls it, an entity controlled by it or an entity controlled by any of them: (a) holds more than one quarter of an Israeli company’s issued capital stock; (b) holds more than one quarter of an Israeli company’s voting power; (c) has the right to appoint more than one quarter of the Israeli company’s directors; or (d) has the right to receive more than one quarter of the Israeli company’s profits; or
    • A non-Israeli company neither registered in Israel nor affiliated with an Israeli company, but maintaining a “place of business” in Israel (by way of a distributor or otherwise), which is reflected by holding a significant influence over the conduct of a local representative (local representative prices, presentation, positioning, identity of customers etc.).

    As mentioned, the Nexus Test must be satisfied by at least two parties in order for the transaction to be considered a "merger of companies".

    Filing Thresholds

    If the transaction is a "merger of companies", and has satisfied the Nexus Test, the transaction must be reported to the Commissioner and receive the Commissioner's approval prior to consummation, if one or more of the following applies:

    • Turnover threshold: the combined turnovers in Israel of the parties to the merger in the balance year prior to the transaction were over NIS 150 million, and at least two parties each had a turnover in Israel of at least NIS 10 million in the same year;
    • Combined market share threshold: the parties' combined market shares will exceed 50% of a product/service market as a result of the merger; or
    • Individual market share threshold: one/both of the parties in the transaction has a "monopoly" (defined by the Israeli Antitrust Law as having over 50% market share) in any market in Israel.

    All the thresholds take a “group” view; namely, they refer to the parties to the transaction, as well as to every company controlled by the same ultimate controlling owners. "Control" is defined in the Israeli Antitrust Law as the possession of more than half of either (i) the right to vote at a company's general meeting or the parallel body of another corporation, or (ii) the right to appoint the directors of a corporation. Turnover thresholds refer to all company activities, not just the activities in the market relevant to the transaction.

    Note that the Israeli Antitrust Law and the Restrictive Trade Practices Regulations (Registry, Publication and Transaction Reporting), 2004 (the "Regulations") do not set an asset threshold to filing in Israel, and whether or not a company has assets in Israel is irrelevant to the thresholds. For example, a hi-tech company may have a development centre in Israel employing several engineers, and still not meet the filing thresholds due to the fact that it has no sales in Israel.

    All thresholds refer to activity in Israel only.

    In this regard, sellers' market share and turnovers will not be taken into account if all connections to the acquired company or assets are severed. If some connections remain between the parties once the transaction has been consummated, the sellers' turnover or market share will be taken into account when assessing the turnovers.

  7. How are turnover, assets and/or market shares valued or determined for the purposes of jurisdictional thresholds?

    Calculation of turnover

    • Turnovers are calculated for the entire group of companies under the same ultimate control. While turnovers, including consolidated turnovers, are calculated according to accepted accounting principles, the question of which entities will be brought into account and included in the consolidated turnovers of the group is set according to antitrust laws. That is, all entities controlled by the same ultimate controlling owner, according to the definition of "control" under Israeli Antitrust Law, will be brought into account, regardless of whether their turnovers are consolidated under accepted accounting principles;
    • Turnovers are calculated for Israel only, and based on accepted accounting principles. In other words – if an entity's turnover is brought into account, the relevant figure will normally be the sales turnover as it appears in its financial reports;
    • The relevant turnovers are the turnovers in the financial year preceding the transaction; i.e. if a transaction occurs during 2019, the relevant turnover will be the 2018 turnover;
    • Sales into Israel from other locations will normally be brought into account, whilst sales from Israel into other territories will normally not be part of the relevant revenue threshold.

    Calculation of market shares

    The definition of markets, the identification of market participants and the allocation of market shares are always some of the most complex and challenging questions presented by competition laws. Nonetheless, we can highlight some principles that apply in the context of Israeli merger control.

    • Market shares refer to the relevant product and geographic market. The full market definition tests are beyond the scope of this essay, but, generally speaking, a relevant market would be one where a hypothetical single actor would be able to profitably raise the price by 5-10% over time without the loss in quantities decreasing its revenues (this is the well-known "hypothetical monopoly test" which is also applied in other jurisdictions).
    • The Israeli Antitrust Authority generally does not provide guidance on market share and market definition issues and the parties must determine the applicability of market share thresholds by themselves. Bona-fide estimates normally suffice in order to determine whether filing is necessary, unless there are specific doubts and concerns that necessitate an expert economic opinion to define markets and measure market shares.
    • The market is not necessarily national. If the parties cross the market share thresholds in a distinct geographic market within Israel, filing is required.

    The Israeli Antitrust Authority prefers to measure market shares by the quantity of products sold. However, this analysis may sometimes be irrelevant, especially in highly-variated product markets. The less homogenous the products, the higher the tendency to calculate market shares by revenue.

  8. Is there a particular exchange rate required to be used to convert turnover and asset values?

    Applicable exchange rates are the average exchange rates over the relevant period; normally the financial year preceding the transaction. If representative rates from the Bank of Israel are available for the relevant currency, these will be the determining rates for calculation of the turnover thresholds.

    The average Bank of Israel representative rates for FY2017 were:

    - US Dollars 3.6177 NIS = 1 USD
    - Euros 4.0462 NIS = 1 EUR

  9. In which circumstances are joint ventures notifiable or reviewable (both new joint ventures and acquisitions of joint control over an existing business)?

    The same thresholds and nexus tests described above apply to joint ventures, if such joint ventures are considered "mergers of companies". Generally speaking, a joint venture will be considered a “merger of companies” if joint control is acquired over an existing business, or existing business activities are transferred to the joint venture.

    Brand new joint ventures commencing a new joint activity may or may not be described as "mergers of companies" depending on the specific characteristics of the venture. As a rule, the more long-term the joint venture and the more "structural" in nature, the higher the tendency to classify it as a merger of companies.

    A joint venture between competitors which does not amount to a "merger of companies" may sometimes be considered a "restrictive arrangement" and require clearance via one of the mechanisms prescribed by the Israeli Antitrust Law for this kind of transaction, including, e.g. specific exemptions or block exemptions.

    Thresholds will be tested by reference to all parties to which the "merger of companies" definition applies, and will certainly apply to every party that will, following the transaction, hold over 25% of one of the rights [detailed in section 4 above] in the joint venture entity. The threshold tests will include the sellers, unless the sellers sell all holdings and sever all ties to the joint venture. If there are additional parties acquiring less than 25% of the joint venture, the applicability of the thresholds to such parties will depend on their specific involvement in the joint venture, e.g. their ability to appoint officers, their role in the conduct of business of the venture and the like.

    Turnovers apply to both the joint venture and its parent companies, and may be satisfied by the latter alone. The Israeli Antitrust Authority has been known to require filing in cases where the parent companies satisfied the relevant nexus and thresholds tests, even when the joint venture itself was not expected to have any activity in Israel.

  10. Are there any circumstances in which different stages of the same, overall transaction are separately notifiable or reviewable?

    Generally, a transaction must be reviewed as a whole. Nonetheless, when the merger transaction itself has different stages, e.g., when it includes an option for future sale or purchase, the future sale or purchase does not have to be reviewed with the main merger transaction. However, if the option itself constitutes a merger (i.e., when the first transaction crosses a holding threshold of 25% of a company’s shares, and the option is for the acquisition of over 50% of the shares), it must be reviewed prior to consummation.

    The Commissioner is sometimes willing to review options at the time of issuance if they are part of a merger transaction currently under review; the merger will be carried out within one year of the date of approval and the options will be exercised no later than three years from the date of approval (the latter period may sometimes be shorter, depending on the specific competitive circumstances).

  11. In relation to “foreign-to-foreign” mergers, do the jurisdictional thresholds vary?

    The nexus tests are the same irrespective of whether the legal entities acquired reside in Israel. If the nexus test and the filing thresholds apply to a group of companies under the same ultimate controlling entity, the nationality of the specific legal entities carrying out the transaction within the group is immaterial.

    Nonetheless, due to various legal constraints, enforcement against non-Israeli entities has been far less vigorous than against local entities.

  12. For voluntary filing regimes (only), are there any factors not related to competition that might influence the decision as to whether or not notify?

    NOT APPLICABLE

  13. What is the substantive test applied by the relevant authority to assess whether or not to clear the merger, or to clear it subject to remedies? Are there different tests that apply to particular sectors?

    The substantive test, as set out in the Israeli Antitrust Law, is "reasonable concern for significant harm to competition or public" in relation to price, quality, quantity or regularity of supply of a product or service.

    The Commissioner discussed horizontal mergers in Opinion 1/11 – Guidelines for The Competitive Analysis of Horizontal Mergers (the "Horizontal Merger Guidelines"). According to the Horizontal Merger Guidelines, the merger review will begin by using a demand-based definition of product and geographic market to identify current participants and market positions. The Israeli Antitrust Authority will estimate possible unilateral effects and coordinated effects, as well as defences such as merger efficiencies and the failing firm doctrine.

    The guidelines indicate that a horizontal merger may raise the Israeli Antitrust Authority's concerns and merit further examination when post-merger market shares are high, the merging companies are the closest substitutes, or entry barriers are high. It should be noted that in some cases when evaluating horizontal mergers, the Israeli Antitrust Authority has been known to use rather narrow market definitions.

    The substantive test set by the Israeli Antitrust Law for vertical mergers is no different from those set for horizontal mergers: "reasonable concern for significant harm to competition or public". According to Antitrust Tribunal precedent, vertical mergers are usually beneficial, although they may raise concerns of foreclosure. The Commissioner rarely objects to mergers based on vertical concerns, but such concerns may result in the imposition of remedies.

  14. Are factors unrelated to competition relevant?

    The Commissioner is only allowed to consider competition factors. Non-competition factors are irrelevant. Nonetheless, efficiency factors may be relevant and will be considered to the extent that the efficiencies are likely to be transferred to the customers, and offset the expected harm to competition from the merger.

    Some merger transactions will also require a sector-specific approval by a sectoral regulator, e.g. in the field of telecommunications.

  15. Are ancillary restraints covered by the authority’s clearance decision?

    Ancillary restraints, such as non-compete clauses, may be considered "restrictive arrangements" and be subject to the general restrictive arrangements chapter of the Israeli Antitrust Law.

    A restrictive arrangement is prohibited unless permitted by one of the mechanisms prescribed by the Israeli Antitrust Law, i.e. approval by the specialist Antitrust Tribunal, exemption from such approval by the Commissioner, falling within the boundaries of one of the statutory exemptions set in the Israeli Antitrust Law itself, or block exemptions issued by the Commissioner.

    A non-compete commitment by a seller following the sale of a business in its entirety, in as much as it would constitute a "restrictive arrangement", is eligible for a statutory exemption when such commitment is "not contrary to reasonable and accepted practices".

    In addition, a specific block exemption has been issued for restraints ancillary to mergers (Antitrust Rules (Block Exemption for Restraints Ancillary to Mergers), 2009), which, under certain conditions, exempts non-compete commitments (for up to four years starting from the decrease in the seller's holdings below 20% and the right to appoint one director); commitments to continued supply under the same terms (for up to three years); and other restraints reasonably required to preserve the value of the acquired business (for a reasonable period of time). This block exemption has several conditions, and inter alia, does not apply to monopolies (defined by the Israeli Antitrust Law as having over a 50% market share).

    Other block exemptions may also apply, such as Antitrust Rules (Block Exemption for Arrangements of Minor Importance), 2006, or Antitrust Rules (Block Exemption for Non-Horizontal Agreements Which Do Not Contain Certain Price Restrictions), 2013.

    In the event that an ancillary restraint does not come within the boundaries of a block exemption, a specific exemption is required. Israeli merger notification forms include a specific chapter with an exemption request form for ancillary restraints.

  16. For mandatory filing regimes, is there a statutory deadline for notification of the transaction?

    Israel has no filing deadline. However, parties to a notifiable merger are prevented from completing the transaction or performing it in any way, including initial steps, prior to receiving the Commissioner's approval.

    The Israeli Antitrust Authority endeavours to meet the standards of leading jurisdictions such as the European Union and the USA, and strives to meet the tight filing schedules. There is generally open communication with Israeli Antitrust Authority representatives and they are often willing to share doubts or questions they may have with the parties.

  17. What is the earliest time or stage in the transaction at which a notification can be made?

    Filing can be made, at earliest, when the transaction has taken a concrete form in a merger agreement. The Israeli Antitrust Authority is normally reluctant to review mergers based on a memorandum of understanding and will only do so in exceptional circumstances based on a specific request from the parties. In these cases, according to the Guidelines, the Israeli Antitrust Authority will start the review itself, but the 30 days allotted to the Commissioner to complete the review will not start until the full merger agreement, including annexes, is presented to the Israeli Antitrust Authority. For publicly-traded companies, the Israeli Antitrust Authority will be willing to review a takeover proposal without an agreement, if an agreement does not exist.

  18. Is it usual practice to engage in pre-notification discussions with the authority? If so, how long do these typically take?

    There are no pre-filing procedures. The IAA will not normally grant the merging parties specific guidance as to how to fill the merger notifications and not involve itself in the parties' market definitions. In competitively simple mergers, the IAA will settle for information requests from the merger parties and normally phone calls with third parties. In more complex cases, the IAA may issue detailed data requests to third parties. This will usually result in a longer review period, due to the time it takes third parties to respond to such written requests.

  19. What is the basic timetable for the authority’s review?

    The Israeli Antitrust Law sets out a 30 calendar-day period after filing notification for the review process to take place. If the Commissioner does not issue a decision within this time, it is seen as an approval. The review process does not have a distinct "phase-2" stage. In some cases, the 30-day review period may be extended formally by the Antitrust Tribunal according to the Commissioner's request, but this is a rare practice. The more common practice is for the Israeli Antitrust Authority to informally request an extension from the merging parties.

    The Israeli Antitrust Authority's average clearance period in 2017 was 21.4 days. In practice, the great majority of mergers are reviewed within the allocated 30-day period although the review of a complex merger may take up to several months.

    The Commissioner must consult with the Advisory Committee Mergers and Exemptions prior to rendering her decision. Normally, the Committee convenes once in every one or two weeks, though in the past it has convened for urgent consultations.

  20. Under what circumstances may the basic timetable be extended, reset or frozen?

    As mentioned above, the merger review period may be extended formally by the Antitrust Tribunal according to the Commissioner's request. This is a rare practice. The more common practice is for the Israeli Antitrust Authority to informally request an extension from the merging parties.

    Requests for information do not stop the clock for the review period, regardless of whether they are answered fully or correctly, nor do negotiations with the parties for remedies or interventions by third parties. Such procedures, if exceeding the 30-day period, will normally be conducted using voluntary extensions from the parties.

    If the merger notifications are incomplete, the clock is reset until full merger notifications are submitted.

  21. Are there any circumstances in which the review timetable can be shortened?

    The Commissioner will issue her decision once the Israeli Antitrust Authority's review has been completed, even before the 30-day review period elapses.

    In 2016 The Israeli Antitrust Authority publicised a "Bright Green Merger" review track, whereby a review may be completed within a timeframe much shorter than the formal 30-day period, based mainly on the information included in the filings themselves.

    For a merger to be reviewed under the "Bright Green Merger" track, the following conditions must apply:

    • The merger clearly does not raise reasonable concerns of competitive harm.
    • The parties use the full merger notification form and not the abbreviated one.
    • The parties include in their filing detailed additional information to help analyse the merger's competitive effects, preferably based on objective resources such as industry surveys.
    • The merger notification is signed by the CEO or chief internal legal counsel of the company. The merger notification will also represent that any information included in the merger notification cover letter, detailing the parties’ competitive arguments, is correct.
  22. Which party is responsible for submitting the filing?

    Both the acquiring party and acquired party must file their own merger notification, describing their own activities, market shares and the like. The Israeli Antitrust Authority will only start its review when both parties have filed their merger notifications. A rare exception may be made when one party refuses to cooperate in the process, such as in the case of a hostile takeover.

  23. What information is required in the filing form?

    The Regulations set a specific merger notification form which must be filed. The extent and kind of information required will depend on the type of merger (horizontal, vertical or "conglomerate", which is a residual definition which applies to mergers that are neither horizontal nor vertical) and on the parties' estimated market shares.

    All mergers will normally require a basic description of the transaction, the filing party's activities and its market shares. Horizontal or vertical mergers, where the parties have over 25% market share, will require some detailed sales information regarding quantities and revenues, as well as further information about the market, such as a description of entry and the switching of barriers. Conglomerate mergers will sometimes require very detailed information about each party's holdings, to ensure that no horizontal or vertical overlaps exist between the parties.

    An abbreviated form may be filed if the parties' combined market shares are less than 30% of the market in which the merger transaction occurs (the "transaction market"); neither party is a monopoly (defined by the Israeli Antitrust Law as having over 50% market share) in a market adjacent to the transaction market, and no party has arrangements or agreements with its competitors in the transaction market. The abbreviated form requires only the most basic information about the parties and their activities, though it requires certain information which is not required by the longer forms, such as identifying the filing party's ultimate controlling owner.

    The forms indicate which parts of the notification will remain confidential. Parts which are not marked as confidential will be published on the Israeli Antitrust Authority's website once the review is concluded and the Commissioner's decision is made public.

  24. Which supporting documents, if any, must be filed with the authority?

    The following supporting documents must be filed with the merger notifications:

    • Annual reports for two years preceding the merger for each party.
    • A full set of the transaction documents, including annexes.
    • Any prospectuses issued by the parties in the five years preceding the mergers.
    • The parties are allowed to file additional documents and information to the extent these are relevant to the competitive analysis of the merger.

    The merger notification forms include a statement of accuracy which must be signed by an officer of the company, whose name and role in the company are indicated on the form. Since the merger notification form itself will normally include the details of the outside attorney as the point of contact for the filing party, no additional power of attorney is required.

  25. Is there a filing fee?

    At the moment, there is no filing fee for merger notifications, though according to the Israeli Antitrust Law, the Minister of Economy and the Minister of Finance may set a filing fee.

  26. Is there a public announcement that a notification has been filed?

    Once the Commissioner's decision is given, the merger is publicly announced in two daily newspapers. The Commissioner's decision and certain non-confidential parts of the merger notification forms will then be published on the Israeli Antitrust Authority's website.

    In addition, the merger review process is considered public and is normally not conducted in a confidential manner. The Israeli Antitrust Authority may approach third parties during the review period, including customers, suppliers and competitors, thus revealing that the merger is about to occur.

  27. Does the authority seek or invite the views of third parties?

    During its merger review process, the Israeli Antitrust Authority approaches third parties, such as customers, suppliers and competitors.

    Such third parties will normally be initially contacted by phone. The Israeli Antitrust Authority will ask them to provide information about the relevant markets, including their input regarding the merger. To the extent required – normally only for more complex mergers – written requests for information will be issued. Under the Israeli Antitrust Law, third parties are obliged to respond to requests for information, and are subject to penalties if they fail to do so in a timely manner.

    The Israeli Antitrust Authority normally does not ask third parties for an opinion in writing, but will accept third parties' written submissions in objection or in support of a merger if filed promptly and within the Israeli Antitrust Authority's review time framework.

  28. What information may be published by the authority or made available to third parties?

    Once the Commissioner's decision is given, the Commissioner's decision and the non-confidential elements of the merger notifications will be scanned and published, unedited, on the Israeli Antitrust Authority's website. Supporting documents, such as financial statements or responses to information requests, will not be published.

    A third party who has the right to appeal the Commissioner's decision will have the right to review the Israeli Antitrust Authority's file, but this will be subject to limitations, including trade secrets. Sometimes information will only be disclosed to outside legal or economic counsel. Certain information may be disclosed according to requests under the Israeli Freedom of Information Law, 1998, again, subject to limitations on disclosure of trade secrets. Nearly any such disclosure is subject to a procedure whereby the suppliers of information are given the opportunity to object to the disclosure of the information they provided.

  29. Does the authority cooperate with antitrust authorities in other jurisdictions?

    The Israeli Antitrust Authority often engages in discussions with antitrust authorities in other jurisdictions, particularly the European Commission.

  30. What kind of remedies are acceptable to the authority?

    In 2011, the Commissioner issued Opinion 2/11 Guidelines on Remedies to Mergers, which Raise Reasonable Concern of Significant Harm to Competition (the "Remedies Guidelines"). According to the Remedies Guidelines, the Israeli Antitrust Authority prefers structural remedies which secure permanent change to the market. Structural remedies require less follow-up and enforcement compared to behavioural remedies, which control the conduct of the merged firm. According to the Remedies Guidelines, the Israeli Antitrust Authority may stipulate behavioural conditions as a temporary solution when:

    • The competitive concerns involve a specific, well-defined behaviour which is easy to detect;
    • A failing company will exit the market entirely without the merger; or
    • Structural conditions are irrelevant.

    In practice, there have been cases where the Israeli Antitrust Authority accepted certain behavioural remedies, including semi-structural remedies such as Chinese walls and personal separation between certain activities of the merged companies.

  31. What procedure applies in the event that remedies are required in order to secure clearance?

    There is no formal procedure or deadline for offering remedies. Under general principles of Israeli constitutional and administrative law, the Commissioner is required to choose the option that is least harmful to the parties' rights, in particular their property rights. If the Israeli Antitrust Authority believes that, at face value, a merger raises reasonable concern of significant harm to competition, it will approach the parties with proposed remedies or request the parties propose possible remedies. The Israeli Antitrust Authority may also impose remedies without the parties' consent. In its final decision, the Commissioner may consider remedies already agreed upon in other jurisdictions and apply them accordingly.

    In cases where divestiture has been required, the Israeli Antitrust Authority has been known to require an up-front buyer in some instances, but settled for later sale in other cases. In some cases, when parties were allowed to carry out the divestiture after the merger, the parties were required to sign documents allowing the automatic transfer of the assets to a trustee who would perform the sale if divestiture of the assets was not carried out within the allocated timeframe. In past cases of divestiture, the Commissioner pre-approved the buyer.

  32. What are the penalties for failure to notify, late notification and breaches of a prohibition on closing?

    Administrative fines are considered the "primary enforcement measure" for failure to notify of the execution of a non-horizontal merger. The maximum fine set by the Israeli Antitrust Law is 8% of a company's total sales turnover in the year prior to the violation, but not more than NIS 24,564,360 (USD ~6 million, EUR ~6 million) in total. For individuals and for companies that in the year prior to the violation had a sales turnover of less than NIS 10,000,000 (USD ~2.7 million, EUR ~2.4 million) the maximum fine is NIS 1,023,510 (USD ~283,000, EUR ~252,000).

    The Commissioner may also issue an Administrative Declaration of Breach. This Declaration serves as prima facie evidence in any legal proceedings, and may be used for civil lawsuits (including class actions), against the merging companies.

    Failing to file a merger notification, or taking action that is tantamount to a full or partial merger contrary to the Israeli Antitrust Law, is a criminal offence. The maximum penalty is a three-year jail sentence, in addition to fines. In practice, criminal sanctions for mergers are rare.

    The Israeli Antitrust Authority may approach the Antitrust Tribunal requesting (i) a consent decree that provides, inter alia, for a specified sum of money to be paid by the parties to the state treasury in lieu of administrative fines, criminal procedures or an administrative declaration. The consent decree may include operative measures, such as the disgorgement of acquired assets. The consent decree may include a provision which provides that the parties do not admit that the "merger of companies" is considered a notifiable merger. The Israeli Antitrust Authority may also approach the Tribunal to request (ii) unconsented divestiture of the merged companies. This is a rare practice: to the best of our knowledge, the antitrust tribunal has considered the separation of merged companies in only two cases in Israel, both cases referring to local companies.

    Last but not least, illegal agreements, including merger agreements, are generally unenforceable (this is also relevant to restraints ancillary to the merger which have not been cleared under the Israeli Antitrust Law). In addition, the consummation of an illegal merger is a civil tort and is subject, even without administrative declaration, to civil law suits, including class actions.

  33. What are the penalties for incomplete or misleading information in the notification or in response to the authority’s questions?

    If the parties received merger clearance based on misleading information, this might constitute the illegal consummation of a merger transaction, subjecting the parties to all of the above mentioned penalties and repercussions, as well as fraud charges.

    In addition, if information was officially required according to the Commissioner's legal power to issue requests for information under the Israeli Antitrust Law, providing incomplete or misleading information may be a separate breach. In this case, administrative fines may be imposed of up to 3% of a company's total sales turnover in the year prior to the violation, up to NIS 8,188,120. For individuals and for companies that in the year prior to the violation had a sales turnover of less than NIS 10 million, the maximum fine is NIS 307,050. This type of breach is also punishable by a criminal sanction of up to a year’s imprisonment and fines.

  34. Can the authority’s decision be appealed to a court?

    Appeals on the Commissioner’s decisions regarding mergers are filed with the specialist Antitrust Tribunal in the Jerusalem District Court.

    A decision to object a merger or approve it under conditions may be appealed by the parties.

    Third parties may appeal the Commissioner’s decision to object or approve a merger (including the conditions for approval) if injured by the merger. Tribunal precedent states that injury must be an “antitrust injury” (i.e., where the source of injury harms competition, and the appellants are the injured party).

    The parties may file an appeal within 30 days of receiving the Commissioner's decision. Third party appeals must be filed within 30 days of the publication of the Commissioner's decision in two daily newspapers. Appeal proceedings may last anywhere between several months to over a year. Antitrust Tribunal decisions may be appealed to the Israeli Supreme Court.

    In practice, few appeals are filed and even fewer reach a decision. This is due to the limited lifespan of many transactions, which become obsolete due to the length of Antitrust Tribunal proceedings.

  35. What are the recent trends in the approach of the relevant authority to enforcement, procedure and substantive assessment?

    There have been several notable trends recently:

    - In 2017 the Israeli Antitrust Authority cut its average review time to 21.4 days. This trend may not continue into 2018, as the IAA has been dealing with several complex mergers and issued several major objections this year.

    - The Israeli Antitrust Authority does not hesitate to object to mergers, even when market shares are small but there are few competitors. For example, the IAA recently objected a merger between two medium-sized banks, even though they have significantly larger competitors.

    - The Israeli Antitrust Authority continues to pursue a policy of vigorous enforcement by means of imposing administrative sanctions. This applies to both gun-jumping and entirely avoiding notification.

  36. Are there any future developments or planned reforms of the merger control regime in your jurisdiction?

    The Israeli Antitrust Authority has announced its intention to advocate legislation to reform the merger control regime. Among other things, the following changes were suggested:

    • Increase in turnover-filing thresholds, so as to include fewer transactions. The market share threshold will not change. This may require entities falling below the new threshold to be more careful.
    • The introduction of a "phase II" investigation period, to allow the Israeli Antitrust Authority to extend the 30-day review term without needing to rely on the Antitrust Tribunal decision or voluntary extensions from the merger parties.
    • Reduction of the maximum jail sentence for an unreported merger from five years to three years, abolishing an ‘aggravating circumstances offence’ which currently exists for mergers and which has never been applied.

    The reform recently passed the first legislation stage in the Knesset (Israeli parliament) and the IAA continues to promote it.

    PLEASE NOTE THAT THE ANSWERS TO THE ABOVE QUESTIONS ARE LIMITED TO A REVIEW OF MERGER CONTROL IN ISRAEL, AS REGULATED BY THE ISRAELI ANTITRUST AUTHORITY

    In 2013, the Israeli Parliament enacted the Law for Promotion of Competition and Reduction of Concentration 2013 (the “Concentration Law”). As the name of the Law indicates, the Concentration Law was aimed at increasing competition in the marketplace. One of the main provisions of the Law prevents the same entity controlling a significant financial entity and a significant non-financial (real) entity. The Concentration Law also requires Israeli regulators to have regard to overall market concentration issues when privatising state-owned companies, granting licences and so on.

    The provisions of the Concentration Law may affect the viability of a potential merger transaction, quite apart from the provisions of the Israeli Antitrust Law. A detailed analysis of the rules set out in the Concentration Law is beyond the scope of the questions in this Comparative Guide.